| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
17,150,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Beyond Air is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit® platform) capable of generating NO from ambient air. The LungFit® platform can generate NO for delivery to a patient's lungs directly or via a ventilator. LungFit® can deliver NO either continuously or for a fixed amount of time at various flow rates and has the ability to either titrate dose on demand or maintain a constant dose. LungFit® can be used to treat patients on ventilators that require NO, as well as patients with chronic or acute severe lung infections via delivery through a breathing mask or similar apparatus.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
1,287,775 |
1,631,439 |
2,092,854 |
| Total Buy Value |
$0 |
$2,106,497 |
$3,046,190 |
$5,942,087 |
| Total People Bought |
0 |
3 |
3 |
7 |
| Total Buy Transactions |
0 |
3 |
7 |
28 |
| Total Shares Sold |
0 |
28,423 |
28,423 |
185,119 |
| Total Sell Value |
$0 |
$59,030 |
$59,030 |
$1,059,643 |
| Total People Sold |
0 |
2 |
2 |
4 |
| Total Sell Transactions |
0 |
3 |
3 |
7 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Carey Robert |
Director |
– • – |
2023-03-30 |
4 |
B |
$6.45 |
$64,500 |
D/D |
10,000 |
886,496 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2023-03-29 |
4 |
B |
$6.30 |
$63,000 |
D/D |
10,000 |
876,496 |
2.39 |
- |
|
| Lee Yoori |
Director |
– • – |
2023-03-28 |
4 |
B |
$6.34 |
$19,749 |
D/D |
3,115 |
12,654 |
2.39 |
- |
|
| Myers Jeff Lynn |
Chief Medical Officer |
• – – |
2023-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Gaul Michael A. |
Chief Operating Officer |
• – – |
2023-03-24 |
4 |
B |
$6.15 |
$6,150 |
D/D |
1,000 |
73,150 |
2.74 |
- |
|
| Bentsur Ron |
Director |
– • – |
2023-03-20 |
4 |
B |
$6.48 |
$14,904 |
D/D |
2,300 |
144,736 |
2.39 |
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2023-03-17 |
4 |
B |
$6.46 |
$64,600 |
D/D |
10,000 |
1,458,696 |
2.81 |
- |
|
| Forbes William P |
Director |
– • – |
2023-03-17 |
4 |
B |
$6.46 |
$32,300 |
D/D |
5,000 |
9,855 |
2.39 |
- |
|
| Lucera Erick |
Director |
– • – |
2023-03-16 |
4 |
B |
$6.82 |
$13,634 |
D/D |
2,000 |
4,342 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2023-03-08 |
4 |
B |
$5.95 |
$59,500 |
D/D |
10,000 |
852,323 |
2.39 |
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2023-03-08 |
4 |
B |
$5.89 |
$29,435 |
D/D |
5,000 |
1,447,849 |
2.81 |
- |
|
| Gaul Michael A. |
Chief Operating Officer |
• – – |
2023-03-07 |
4 |
B |
$5.86 |
$46,880 |
D/D |
8,000 |
72,150 |
2.74 |
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2023-03-07 |
4 |
B |
$5.98 |
$268,920 |
D/D |
45,000 |
1,442,849 |
2.81 |
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2023-02-16 |
4 |
S |
$6.10 |
$296,436 |
D/D |
(48,596) |
1,397,849 |
|
- |
|
| Carey Robert |
Director |
– • – |
2022-12-07 |
4 |
B |
$5.75 |
$115,000 |
D/D |
20,000 |
842,323 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2022-11-29 |
4 |
B |
$5.75 |
$86,249 |
D/D |
15,000 |
822,323 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2022-11-28 |
4 |
B |
$5.75 |
$86,243 |
D/D |
15,000 |
807,323 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2022-11-18 |
4 |
B |
$5.80 |
$116,000 |
D/D |
20,000 |
792,323 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2022-11-17 |
4 |
B |
$5.90 |
$118,000 |
D/D |
20,000 |
772,323 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2022-11-16 |
4 |
B |
$6.00 |
$60,000 |
D/D |
10,000 |
752,323 |
2.39 |
- |
|
| Gaul Michael A. |
Chief Operating Officer |
• – – |
2022-08-22 |
4 |
B |
$9.42 |
$18,840 |
D/D |
2,000 |
64,150 |
2.74 |
- |
|
| Gaul Michael A. |
Chief Operating OfficerOfficer |
• – – |
2022-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
62,150 |
|
- |
|
| Bentsur Ron |
Director |
– • – |
2022-06-30 |
4 |
S |
$6.53 |
$261,104 |
D/D |
(40,000) |
142,436 |
|
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2022-06-30 |
4 |
B |
$6.63 |
$483,698 |
D/D |
73,000 |
1,446,445 |
2.81 |
- |
|
| Carey Robert |
Director |
– • – |
2022-06-30 |
4 |
B |
$6.45 |
$1,128,295 |
D/D |
175,000 |
742,323 |
2.39 |
- |
|
49 Records found
|
|
Page 1 of 2 |
|
|
